用巴瑞替尼成功治疗斑秃相关的毛周角化病。 - Suppr

Suppr

超能文献

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

作者信息

Rózsa Petra, Degovics Döníz, Baltás Eszter, Gyulai Rolland, Kemény Lajos

机构信息

Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.

出版信息

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

DOI:10.1111/ijd.17137

PMID:38514896

Abstract

摘要

相似文献

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

Baricitinib in Alopecia Areata.

N Engl J Med. 2022 May 5;386(18):1751-1752. doi: 10.1056/NEJMe2203440.

Oral Baricitinib Restores Hair Loss in Alopecia Areata.

JAMA. 2022 Jun 28;327(24):2386. doi: 10.1001/jama.2022.10378.

A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System.

Mil Med. 2025 Jan 16;190(1-2):e67-e73. doi: 10.1093/milmed/usae292.

Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.

J Dermatol. 2025 Apr;52(4):701-711. doi: 10.1111/1346-8138.17641. Epub 2025 Jan 27.

Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study.

J Cosmet Dermatol. 2025 Feb;24(2):e16666. doi: 10.1111/jocd.16666. Epub 2024 Nov 20.

Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure.

Arch Dermatol Res. 2025 Feb 25;317(1):491. doi: 10.1007/s00403-025-04035-y.

Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinib.

Clin Exp Dermatol. 2024 Jul 19;49(8):875-878. doi: 10.1093/ced/llae033.

Two Phase 3 Trials of Baricitinib for Alopecia Areata.

N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.

[Translated article] RF - Recent Approval of Baricitinib for Alopecia Areata: Safety and Efficacy Data.

Actas Dermosifiliogr. 2023 Sep;114(8):T718-T719. doi: 10.1016/j.ad.2022.10.051. Epub 2023 Jul 13.

引用本文的文献

JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential.

Am J Clin Dermatol. 2025 Apr 23. doi: 10.1007/s40257-025-00946-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

作者信息

Rózsa Petra, Degovics Döníz, Baltás Eszter, Gyulai Rolland, Kemény Lajos

机构信息

Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.

出版信息

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

DOI:10.1111/ijd.17137

PMID:38514896

Abstract

摘要

相似文献

Successful treatment of alopecia areata-associated trachyonychia with baricitinib.

Int J Dermatol. 2024 Aug;63(8):1089-1090. doi: 10.1111/ijd.17137. Epub 2024 Mar 21.

Baricitinib in Alopecia Areata.

N Engl J Med. 2022 May 5;386(18):1751-1752. doi: 10.1056/NEJMe2203440.

Oral Baricitinib Restores Hair Loss in Alopecia Areata.

JAMA. 2022 Jun 28;327(24):2386. doi: 10.1001/jama.2022.10378.

A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System.

Mil Med. 2025 Jan 16;190(1-2):e67-e73. doi: 10.1093/milmed/usae292.

Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.

J Dermatol. 2025 Apr;52(4):701-711. doi: 10.1111/1346-8138.17641. Epub 2025 Jan 27.

Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study.

J Cosmet Dermatol. 2025 Feb;24(2):e16666. doi: 10.1111/jocd.16666. Epub 2024 Nov 20.

Switching JAK inhibitors: evaluating baricitinib's effectiveness in alopecia areata after tofacitinib failure.

Arch Dermatol Res. 2025 Feb 25;317(1):491. doi: 10.1007/s00403-025-04035-y.

Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinib.

Clin Exp Dermatol. 2024 Jul 19;49(8):875-878. doi: 10.1093/ced/llae033.

Two Phase 3 Trials of Baricitinib for Alopecia Areata.

N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.

[Translated article] RF - Recent Approval of Baricitinib for Alopecia Areata: Safety and Efficacy Data.

Actas Dermosifiliogr. 2023 Sep;114(8):T718-T719. doi: 10.1016/j.ad.2022.10.051. Epub 2023 Jul 13.

引用本文的文献

JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential.

Am J Clin Dermatol. 2025 Apr 23. doi: 10.1007/s40257-025-00946-8.